Search

everythinglearnresearchcommunity

for

Search:↓

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

The research shows that hydrogen bonds greatly affect the crystal structure of a Finasteride derivative.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

CT scans can find serious prostate cancer even when PSA levels are low.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Testosterone significantly affects urination differences between male and female mice.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.